Policy statement - Rabies-prevention policy update: New reduced-dose schedule

Michael T. Brady; Henry H. Bernstein; Carrie L. Byington; Kathryn M. Edwards; Margaret C. Fisher; Mary P. Glode; Mary Anne Jackson; Harry L. Keyserling; David W. Kimberlin; Yvonne A. Maldonado; Walter A. Orenstein; Gordon E. Schutze; Rodney E. Willoughby

doi:10.1542/peds.2011-0095

Policy statement - Rabies-prevention policy update: New reduced-dose schedule

Michael T. Brady, Henry H. Bernstein, Carrie L. Byington, Kathryn M. Edwards, Margaret C. Fisher, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, David W. Kimberlin, Yvonne A. Maldonado, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby

Research output: Contribution to journal › Short survey › peer-review

8 Scopus citations

Abstract

The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.

Original language	English (US)
Pages (from-to)	785-787
Number of pages	3
Journal	Pediatrics
Volume	127
Issue number	4
DOIs	https://doi.org/10.1542/peds.2011-0095
State	Published - Apr 2011

Keywords

Bites and stings
Guidelines
Immunization
Immunization schedule
Passive
Prevention and control
Rabies
Vaccines

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2011-0095

Cite this

Brady, M. T., Bernstein, H. H., Byington, C. L., Edwards, K. M., Fisher, M. C., Glode, M. P., Jackson, M. A., Keyserling, H. L., Kimberlin, D. W., Maldonado, Y. A., Orenstein, W. A., Schutze, G. E., & Willoughby, R. E. (2011). Policy statement - Rabies-prevention policy update: New reduced-dose schedule. Pediatrics, 127(4), 785-787. https://doi.org/10.1542/peds.2011-0095

Policy statement - Rabies-prevention policy update : New reduced-dose schedule. / Brady, Michael T.; Bernstein, Henry H.; Byington, Carrie L.; Edwards, Kathryn M.; Fisher, Margaret C.; Glode, Mary P.; Jackson, Mary Anne; Keyserling, Harry L.; Kimberlin, David W.; Maldonado, Yvonne A.; Orenstein, Walter A.; Schutze, Gordon E.; Willoughby, Rodney E.

In: Pediatrics, Vol. 127, No. 4, 04.2011, p. 785-787.

Research output: Contribution to journal › Short survey › peer-review

Brady, Michael T. ; Bernstein, Henry H. ; Byington, Carrie L. ; Edwards, Kathryn M. ; Fisher, Margaret C. ; Glode, Mary P. ; Jackson, Mary Anne ; Keyserling, Harry L. ; Kimberlin, David W. ; Maldonado, Yvonne A. ; Orenstein, Walter A. ; Schutze, Gordon E. ; Willoughby, Rodney E. / Policy statement - Rabies-prevention policy update : New reduced-dose schedule. In: Pediatrics. 2011 ; Vol. 127, No. 4. pp. 785-787.

@article{507af743c8c14972bc6801dc9ea9b492,

title = "Policy statement - Rabies-prevention policy update: New reduced-dose schedule",

abstract = "The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.",

keywords = "Bites and stings, Guidelines, Immunization, Immunization schedule, Passive, Prevention and control, Rabies, Vaccines",

author = "Brady, {Michael T.} and Bernstein, {Henry H.} and Byington, {Carrie L.} and Edwards, {Kathryn M.} and Fisher, {Margaret C.} and Glode, {Mary P.} and Jackson, {Mary Anne} and Keyserling, {Harry L.} and Kimberlin, {David W.} and Maldonado, {Yvonne A.} and Orenstein, {Walter A.} and Schutze, {Gordon E.} and Willoughby, {Rodney E.}",

year = "2011",

month = apr,

doi = "10.1542/peds.2011-0095",

language = "English (US)",

volume = "127",

pages = "785--787",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "4",

}

TY - JOUR

T1 - Policy statement - Rabies-prevention policy update

T2 - New reduced-dose schedule

AU - Brady, Michael T.

AU - Bernstein, Henry H.

AU - Byington, Carrie L.

AU - Edwards, Kathryn M.

AU - Fisher, Margaret C.

AU - Glode, Mary P.

AU - Jackson, Mary Anne

AU - Keyserling, Harry L.

AU - Kimberlin, David W.

AU - Maldonado, Yvonne A.

AU - Orenstein, Walter A.

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

PY - 2011/4

Y1 - 2011/4

N2 - The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.

AB - The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.

KW - Bites and stings

KW - Guidelines

KW - Immunization

KW - Immunization schedule

KW - Passive

KW - Prevention and control

KW - Rabies

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=79953305464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953305464&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-0095

DO - 10.1542/peds.2011-0095

M3 - Short survey

C2 - 21444598

AN - SCOPUS:79953305464

VL - 127

SP - 785

EP - 787

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -

Policy statement - Rabies-prevention policy update: New reduced-dose schedule

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this